Lung/Thoracic Oncology News & Articles

81 Amiodarone is a cost-neutral way of preventing atrial fibrillation after surgery for lung cancer European Journal of Cardio-Thoracic Surgery, May 10, 2013    Clinical Article

82 High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: A preliminary study Journal of Medical Imaging and Radiation Oncology, May 10, 2013    Clinical Article

83 Serendipitous Discovery of Non-Sestamibi-Avid Squamous Cell Lung Cancer Invading the Heart During Myocardial Perfusion Imaging Clinical Nuclear Medicine , May 10, 2013

84 Association between tuberculosis infections and non-pulmonary malignancies: a nationwide population-based study British Journal of Cancer, May 9, 2013

85 Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell–like Properties in Cancer Cells Cancer Research, May 9, 2013    Clinical Article

86 Free drugs in clinical trials and their potential cost saving impact on the National Health Service: A retrospective cost analysis in Italy Lung Cancer, May 9, 2013    Review Article

87 Prognostic parameters for acute esophagus toxicity in Intensity Modulated Radiotherapy and concurrent chemotherapy for locally advanced non-small cell lung cancer Radiotherapy & Oncology, May 9, 2013    Clinical Article

88 Reirradiation and stereotactic radiotherapy for tumors in the lung: Dose summation and toxicity Radiotherapy & Oncology, May 9, 2013    Clinical Article

89 Dual modulation of JNK and Akt signaling pathways by chaetoglobosin K in human lung carcinoma and ras-transformed epithelial cells Investigational New Drugs, May 9, 2013    Clinical Article

90 Low papillary structure in lepidic growth component of lung adenocarcinoma: a unique histologic hallmark of aggressive behavior Human Pathology, May 9, 2013    Clinical Article

91 Thymidylate Synthase Gene Copy Number as a Predictive Marker for Response to Pemetrexed Treatment of Lung Adenocarcinoma Anticancer Research, May 9, 2013    Clinical Article

92 X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population Tumor Biology, May 9, 2013    Evidence Based Medicine

93 Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer Medical Oncology, May 9, 2013    Clinical Article

94 PF02341066 Sensitizes EML4-ALK NSCLC Cells to Radiation Treatment Molecular Cancer Therapeutics, May 9, 2013    Clinical Article

95 Long-Term Results of a Randomized, Double-Blind, and Placebo-Controlled Phase III Trial: Endostar (rh-Endostatin) Versus Placebo in Combination with Vinorelbine and Cisplatin in Advanced Non-Small Cell Lung Cancer Thoracic Cancer, May 9, 2013    Clinical Article

96 Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer European Journal of Cardio-Thoracic Surgery, May 9, 2013    Review Article

97 Toward Personalized Medicine of Lung Cancer: Response to Nontargeted Therapy in Invasive Pulmonary Adenocarcinoma as a Function of Tumor Cell Differentiation International Journal of Surgical Pathology, May 9, 2013    Review Article

98 Differential genomic alterations in normal and cancerous lung cells in response to chronic inflammation Full Text Translational Cancer Research , May 9, 2013    Review Article

99 A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer Investigational New Drugs, May 8, 2013    Clinical Article

100 Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: The CAPPA-2 study Lung Cancer, May 8, 2013    Clinical Article

1 Radiotherapy for lung tumors arising after a prior pneumonectomy Journal of Thoracic Disease, April 8, 2013    Free full text

2 Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer Cancer, April 10, 2013

3 Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis Journal of the National Cancer Institute, April 19, 2013    Evidence Based Medicine

4 Prediagnosis soy food consumption and lung cancer survival in women Journal of Clinical Oncology, April 1, 2013

5 Thymidylate synthase and ERCC1 as predictive markers in patients with pulmonary adenocarcinoma treated with pemetrexed and cisplatin Lung Cancer, April 2, 2013

6 Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study The Lancet Oncology, April 18, 2013

7 The effectiveness of erlotinib against brain metastases in non-small cell lung cancer patients American Journal of Clinical Oncology, March 28, 2013

8 Diabetes mellitus as an independent risk factor for lung cancer: A meta-analysis of observational studies European Journal of Cancer, April 11, 2013    Review Article

9 Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small-cell lung cancer Chinese Journal of Cancer Research, April 16, 2013    Free full text

10 Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas Lung Cancer, April 12, 2013

11 Effects of erlotinib first-line maintenance therapy versus placebo on the health-related quality of life of patients with metastatic non-small-cell lung cancer European Journal of Cancer, March 18, 2013

12 A multicenter Phase II study of ganetespib monotherapy in patients with genotypically-defined advanced non-small cell lung cancer Clinical Cancer Research, April 9, 2013

13 Novel therapeutic targets in non-small cell lung cancer Current Opinion in Pharmacology , April 29, 2013    Review Article

14 Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancer Lung Cancer, April 2, 2013

15 Treatment of stage IIIb/IV non-small cell lung cancer with Pemetrexed plus Oxaliplatin after failure of Erlotinib as second-line treatment Medical Oncology, April 15, 2013

16 The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: Results of a prospective study with mature survival data Radiotherapy & Oncology, April 4, 2013

17 Randomized phase II study of ixabepilone or paclitaxel plus carboplatin in patients with non-small-cell lung cancer prospectively stratified by beta-3 tubulin status Journal of Clinical Oncology, April 25, 2013

18 Cruciferous vegetables consumption and the risk of female lung cancer: a prospective study and a meta-analysis Annals of Oncology, April 9, 2013    Review Article

19 The prognostic and predictive value of KRAS oncogene substitutions in lung adenocarcinoma Cancer, March 26, 2013

20 Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma British Journal of Cancer, April 8, 2013